Company: NGVT
Filing Date: 2025-08-05
Form Type: 10-Q
Source: 0001653477-25-000108
Chunk: 13

Company: Ingevity Corp
Filing Date: 2025-08-05
Form: 10-Q
Item: Part I, Item 1
Chunk 13
---
.7)Total foreign currency adjustments, net of tax provision (benefit) of zero for all periods29.5 (2.6)46.7 (11.7)Derivative instruments:Unrealized gain (loss), net of tax provision (benefit) of $(0.4), zero, $(0.4) and $(0.1)(1.4)0.1 (1.3)(0.2)Reclassifications of deferred derivative instruments (gain) loss, included in net income (loss), net of tax (provision) benefit of zero, $0.2, $0.1 and $0.40.1 0.6 0.2 1.1 Total derivative instruments, net of tax provision (benefit) of $(0.4), $0.2, $(0.3) and $0.3(1.3)0.7 (1.1)0.9 Other comprehensive income (loss), net of tax provision (benefit) of $(0.4), $0.2, $(0.3) and $0.328.2 (1.9)45.6 (10.8)Comprehensive income (loss)$(118.3)$(285.6)$(80.4)$(350.5)

The accompanying notes are an integral part of these financial statements.

4

INGEVITY CORPORATION

Condensed Consolidated Balance Sheets In millions, except share and par value dataJune 30, 2025December 31, 2024Assets(Unaudited)Cash and cash equivalents$76.9 $68.0 Accounts receivable, net of allowance of $1.0 - 2025 and $0.6 - 2024193.4 141.0 Inventories, net220.3 226.8 Prepaid and other current assets45.4 57.4 Current assets536.0 493.2 Property, plant, and equipment, net654.6 658.9 Operating lease assets, net39.4 50.4 Goodwill4.3 175.2 Other intangibles, net279.1 278.8 Deferred income taxes118.5 117.9 Restricted investment, net of allowance of $0.2 - 2025 and $0.2 - 202483.0 81.